Shopping News / Articles
The Spectator Australia
spectator. com. au > 2026 > 05 > gene-editing-drugs-are-opening-a-new-frontier-in-medicine

Gene-editing drugs are opening a new frontier in medicine

14+ hour, 13+ min ago  (332+ words) Older readers with bulging medicine cabinets, or parents eyeing their children's distant futures, are not encouraged to read the New England Journal of Medicine " despite its prestige. A paper just published there, however, matters to them and to me. "In…...

Symbols: nasdaq:crsp,nasdaq:vrtx
@CIDRAP
cidrap. umn. edu > covid-19 > better-prepandemic-heart-health-may-help-prevent-severe-covid

Better prepandemic heart health may help prevent severe COVID

2+ hour, 3+ min ago  (1159+ words) Adults with healthier hearts before the pandemic were nearly half as likely to have severe COVID-19 than those with poorer heart health, suggests a'study published in the Journal of the American Heart Association. The average participant age was 66. 1years, 61% were women,…...

Symbols: covid-19
freerepublic. com
freerepublic. com > focus > f-news > 4381194 > posts

Senator Ron Johnson Says FDA Concealed COVID Vaccine Risks

1+ hour, 49+ min ago  (534+ words) Wisconsin Senator Ron Johnson is taking aim at the FDA, accusing the agency of concealing COVID vaccine injuries and calling it 'the largest government scandal in my lifetime.' He joined Fox News host Maria Bartiromo and others to discuss the…...

Yahoo Finance
finance. yahoo. com > sectors > healthcare > articles > edesa-biotech-present-data-paridiprubart-131500125. html

Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference

1+ week, 1+ day ago  (135+ words) Oral presentation at ERA Congress, the flagship European nephrology meeting Company expects to present additional data Edesa's accepted oral presentation will feature exploratory data and analysis from the company's study of paridiprubart in patients with respiratory distress who also experienced…...

Symbols: nasdaq:icu
markets. businessinsider. com
markets. businessinsider. com > news > stocks > palvella-therapeutics-to-present-qtorin-rapamycin-results-from-phase-3-selva-and-phase-2-toiva-studies-at-the-international-society-for-the-study-of-vascular-anomalies-world-congress-2026-1036037533

Palvella Therapeutics to Present QTORIN" Rapamycin Results from Phase 3 SELVA and Phase 2 TOIVA Studies at the International Society for the Study of Vascular Anomalies World Congress 2026

1+ mon, 1+ week ago  (248+ words) James Treat, MD, Professor of Clinical Pediatrics and Dermatology at the Children's Hospital of Philadelphia to present clinical results on Wednesday, May 20, 2026, at 4: 30 p. m. ET WAYNE, Pa. , April. .. Palvella Therapeutics to Present QTORIN" Rapamycin Results from Phase 3 SELVA and Phase 2 TOIVA…...

Symbols: nasdaq:pvla
TODAY. com
today. com > health > diet-fitness > weight-loss-tips-without-glp-1-drugs-rcna346964

Man Who Lost 70 Pounds Without GLP-1 Drug Shares His No. 1 Strategy and Simple Tips

1+ hour, 15+ min ago  (973+ words) Summer Finds Under $40: UV Stickers, XL Beach Blanket, More Nathan Coleman still remembers the exact moment he vowed to lose weight " a "turning point" that led him to shed 70 pounds without GLP-1 weight-loss drugs. It started with a horse. Coleman…...

Symbols: arpa-h,otcmkts:psru,glp-1s
Med City News
medcitynews. com > 2026 > 04 > intellia-crispr-in-vivo-gene-editing-hereditary-angioedema-hae-rare-disease-ntla

Intellia's Data Reveal Tees Up FDA Filing for CRISPR-Based In Vivo Gene-Editing Med

1+ mon, 30+ min ago  (247+ words) Intellia Therapeutics" lonvo-z uses CRISPR to inactivate a gene in the liver to reduce levels of a protein key to the swelling attacks from the rare disease hereditary angioedema. Intellia has filed a regulatory submission for this genetic medicine, which…...

Symbols: lonvo-z
CNBC
cnbc. com > 04/27/2026 > crispr-gene-editing-intellia-trial. html

Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

1+ mon, 2+ hour ago  (449+ words) Intellia Therapeutics said its Crispr-based treatment for a rare swelling condition met its goals in a late-stage trial, marking a milestone for the field of gene editing and putting the company on track to seek approval from the U. S. Food and…...

Symbols: attr-cm,lonvo-z,nasdaq:ntla
Los Angeles Business Journal
labusinessjournal. com > featured > amgen-drug-reviewed-amid-deaths

Amgen Drug Reviewed Amid Deaths

1+ day, 16+ hour ago  (563+ words) The deaths of 20 patients in Japan have prompted scrutiny of a drug produced by Thousand Oaks-based Amgen. Sales of the problematic Amgen Inc. drug Tavneos resumed late last week in Japan with a new warning label after several patient deaths…...

Symbols: nasdaq:amgn,btc-usd
STAT
statnews. com > 01/16/2025 > huntingtons-disease-new-research-into-cause-of-brain-ravaging-condition

Studies reveal a new biology of Huntington's, renewing drugmaker interest in therapies

3+ week, 5+ day ago  (231+ words) STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts, and opinion pieces. We tell our stories…...

Symbols: nasdaq:qure
Shopping

Please enter a search for detailed shopping results.